Maxwell Finland | |
---|---|
Максвелл Фінланд | |
Born | |
Died | October 25, 1987 85) | (aged
Occupation(s) | Scientist, medical researcher, infectious disease expert |
Maxwell Finland [lower-alpha 1] (March 15, 1902 – October 25, 1987) was an American scientist, medical researcher, and an expert on infectious diseases. [1] [2] [3] [4] Finland led seminal research of antibiotic treatment of pneumonia. [1]
Finland was born on March 15, 1902, in Zhashkiv near Kyiv, Ukraine. He immigrated as a child to the United States at the age of 4. Finland graduated from the Boston English High School and cum laude from Harvard College in 1922. He then graduated from Harvard Medical School in 1926. [4]
In 1944, he worked with Chester Keefer at the Boston City Hospital on the first studies using penicillin to treat infectious diseases. [5]
He was noted for his strong criticism of pharmaceutical companies for their marketing of fixed-dose antibiotics. [6] His outspoken criticism helped in withdrawal of those drugs from the market. [1] [7] He also made significant contributions to early identifications of new infectious issues, such as resistances of bacteria to antibiotics. [1]
Finland was a member of the National Academies of Sciences. [3] His name appeared on about 800 scientific papers. [1] Finland turned over the money he received for numerous awards to Harvard endowment. [1] It is estimated that between his money and the money he influenced companies to give to the school, the total contribution was around 6 million dollars. [1] An annual Maxwell Finland Award was established in 1988 by the National Foundation for Infectious Diseases. [2] The National Academies Press called Finland "a giant in the field of infectious diseases". [3] National Foundation for Infectious Diseases called Finland "a distinguished scholar and scientist who pioneered work in epidemiology and antimicrobial resistance, and helped define the discipline of infectious diseases as we know it today". [2] [8]
A building on the Boston University School of Medicine campus on Albany Street is named The Maxwell Finland Building and has housed The Maxwell Finland Laboratory for Infectious Diseases. [9]
Stanley Ben Prusiner is an American neurologist and biochemist. He is the director of the Institute for Neurodegenerative Diseases at University of California, San Francisco (UCSF). Prusiner discovered prions, a class of infectious self-reproducing pathogens primarily or solely composed of protein, a scientific theory considered by many as a heretical idea when first proposed. He received the Albert Lasker Award for Basic Medical Research in 1994 and the Nobel Prize in Physiology or Medicine in 1997 for research on prion diseases developed by him and his team of experts beginning in the early 1970s.
Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.
Martin J. Blaser is an American physician who is the director of the Center for Advanced Biotechnology and Medicine at Rutgers (NJ) Biomedical and Health Sciences and the Henry Rutgers Chair of the Human Microbiome and Professor of Medicine and Pathology and Laboratory Medicine at the Rutgers Robert Wood Johnson Medical School in New Jersey.
Paul Allan Offit is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine. Offit is the Maurice R. Hilleman Professor of Vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, former chief of the Division of Infectious Diseases (1992–2014), and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia.
The Infectious Diseases Society of America (IDSA) is a medical association representing physicians, scientists, and other healthcare professionals who specialize in infectious diseases. It was founded in 1963 and is based in Arlington, Virginia. As of 2018, IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. It is a 501(c)(6) organization.
Harvey Vernon Fineberg is an American physician. A noted researcher in the fields of health policy and medical decision making, his past research has focused on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations. Fineberg has held several prominent positions over the course of his career, including Dean of the Harvard School of Public Health, Provost of Harvard University, and President of the Institute of Medicine, now the National Academy of Medicine.
William Bosworth Castle was an American physician and physiologist who transformed hematology from a "descriptive art to a dynamic interdisciplinary science."
Robert Austrian was an American infectious diseases physician and, along with Maxwell Finland, one of the two most important researchers into the biology of Streptococcus pneumoniae in the 20th century.
Joia Stapleton Mukherjee is an associate professor with the Division of Global Health Equity at the Brigham and Women's Hospital and the Department of Global Health and Social Medicine at Harvard Medical School. Since 2000, she has served as the Chief Medical Officer of Partners In Health, an international medical non-profit founded by Paul Farmer, Ophelia Dahl, and Jim Kim. She trained in Infectious Disease, Internal Medicine, and Pediatrics at the Massachusetts General Hospital and has an MPH from Harvard School of Public Health. Dr. Mukherjee has been involved in health care access and human rights issues since 1989, and she consults for the World Health Organization on the treatment of HIV and MDR-TB in developing countries. Her scholarly work focuses on the human rights aspect of HIV treatment and on the implementation of complex health interventions in resource-poor settings.
Jay Philip Sanford was a noted American military physician and infectious disease specialist. He held a chair in Tropical Medicine and was author of The Sanford Guide to Antimicrobial Therapy. From 1975 until 1990, he was dean, then president, of the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He received numerous lifetime honors, awards, and accolades.
Stuart Blank Levy was a researcher and physician at Tufts University. He was among the first to advocate for greater awareness of antibiotic resistance and founded the Alliance for the Prudent Use of Antibiotics.
Chronic Lyme disease (CLD) is the name used by some people with non-specific symptoms, such as fatigue, muscle pain, and cognitive dysfunction to refer to their condition, even if there is no evidence that they had Lyme disease. Both the label and the belief that these people's symptoms are caused by this particular infection are generally rejected by medical professionals. Chronic Lyme disease is distinct from post-treatment Lyme disease syndrome, a set of lingering symptoms which may persist after successful antibiotic treatment of infection with Lyme-causing Borrelia bacteria, and which may have similar symptoms to those associated with CLD.
Barry R. Bloom is Joan L. and Julius H. Jacobson Professor of Public Health, Emeritus in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health, where he served as dean of the faculty from 1998 through December 31, 2008.
Dimitrios P. Kontoyiannis is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. He received his medical degree as valedictorian Summa Cum Laude from the National and Kapodistrian University of Athens, Greece. Kontoyiannis was trained in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a master's degree in Clinical Sciences from Harvard Medical School in Boston. He spent three years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program.
Gerald T. Keusch is an American physician-scientist and academic administrator. Keusch is the associate provost for global health at Boston University Medical Campus and a professor of international health and medicine at Boston University School of Public Health. He was the director of John E. Fogarty International Center and the associate director of international research at the National Institutes of Health from 1998 to 2003.
George Louis Drusano is an American physician and medical researcher.
Helen Boucher is an American physician and infectiologist who is the dean of the Tufts University School of Medicine and the Chief Academic Officer of Tufts Medicine, the parent health system for Tufts Medical Center in Boston. She is the first woman to serve as the dean of the Tufts University School of Medicine.
Liise-anne Pirofski is a Professor of Medicine, Microbiology and Immunology at Albert Einstein College of Medicine and Montefiore Medical Center. She is a Member of the Association of American Physicians, and a Fellow of the American Association for the Advancement of Science, American Academy of Microbiology, American College of Physicians and the Infectious Diseases Society of America.
Robin Patel is a Canadian born microbiologist and Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of Microbiology, and a Professor of Medicine at the Mayo Clinic. She is widely recognized as a leader in the field of clinical microbiology and has held a variety of leadership positions including 2019–2020 President of the American Society for Microbiology (ASM) and Director of the Antibacterial Resistance Leadership Group (ARLG) Laboratory Center of the National institutes of Health. She is currently the Vice Chair of Education in the Department of Laboratory Medicine and Pathology at the Mayo Clinic, and Director of the Mayo Clinic's Infectious Diseases Research Laboratory, where she studies biofilms, antimicrobial resistance, periprosthetic joint infection and diagnostic testing of bacteria.
Celia Judith Maxwell is an American infectious disease physician and academic administrator. She is the associate dean for research and a professor of medicine at the Howard University College of Medicine.